{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-25-000052","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.806868+00:00","generated_at":"2026-05-21T19:58:29.630851+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Integra LifeSciences shareholders approve 2.2M share increase in equity plan; chairman transitions to non-executive role","bullets":["Stockholders approved Amendment No. 2 to increase shares under equity plan by 2.2M, to 20.7M total.","All nine director nominees elected at May 9 annual meeting; PwC ratified as auditor; say-on-pay approved.","Board approved transition of Dr. Essig from Executive Chairman to non-executive Chairman effective July 1, 2025; no disagreement.","Plan amendment eliminates provision allowing shares withheld for taxes to be returned to the plan."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-25-000052","json":"https://secwatch.observer/filing/0000917520-25-000052.json","markdown":"https://secwatch.observer/filing/0000917520-25-000052.md","text":"https://secwatch.observer/filing/0000917520-25-000052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000052/0000917520-25-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000052/iart-20250509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T19:58:29.630851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}